drugset / Trial / NCT02737358
N-acetylcysteine for Tobacco Use Disorder
Phase 2
Completed
114 enrolled
Medical University of South Carolina
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the effects of administering N-Acetylcysteine (NAC) to assist in initial cessation and/or relapse prevention in adult cigarette smokers.
Timeline
- Start
- 2016-08-30
- Primary completion
- 2019-08-01
- Completion
- 2019-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 1200 mg | — |